Methods	RCT, 2-arm trial.
Participants	Setting: 40 women, setting not clear. Inclusion criteria: women with gestational age 40-42 weeks, singleton, cephalic presentation, intact membranes, Bishop score < 6, reassuring FHR and < 3 contractions in 10 minutes
Interventions	Intervention group: 100 mg oral misoprostol, dose repeated every 24 hrs with max of 3 doses. 2 hrs continual fetal monitoring after each dose Comparison group: placebo, with same regime and monitoring as the intervention group
Outcomes	Chorioamnionitis, meconium aspiration, uterine hyperstimulation, mean time to active labour
Notes	Study reported in brief abstract.
Risk of bias
Item	Authors’ judgement	Description
Adequate sequence generation?	Unclear	Described as “randomized”.
Allocation concealment?	Unclear	Placebo controlled, no information on randomisation procedure
Blinding? Women	Yes	Described as double-blind, placebo controlled study.
Blinding? Clinical staff	Yes
Blinding? Outcome assessor	Unclear	Not described.
Incomplete outcome data addressed? All outcomes	Unclear	All women appeared to have been followed up, but little information